Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Viriom Initiates Phase 2 Clinical Study of Elsulfavirine for COVID-19

americanpharmaceuticalreviewApril 13, 2020

Tag: Viriom , Elsulfavirine , COVID-19

PharmaSources Customer Service